Vigilant Biosciences Cleared to Launch its Oral Cancer Test Across Europe

Vigilant Biosciences Cleared to Launch its Oral Cancer Test Across Europe May 4, 2016 Vigilant Biosciences, an early-stage Fort Lauderdale-based company that develops solutions that aid in the early detection and intervention of cancer, announced that it has CE Marked its OncAlert Oral Cancer RAPID Test, meaning it can market the product in the 28

Fort Lauderdale Company’s CancerTest Receives European Marketing Approval

Fort Lauderdale Company’s CancerTest Receives European Marketing Approval May 4, 2016 Vigilant Biosciences, a startup company in Fort Lauderdale, has received European Commission approval to market its oral cancer testing product. European approval to sell the product “is a major milestone for our company as it enables us to initiate manufacturing and sales efforts across

Vigilant Biosciences Receives CE Mark for OncAlert® Oral Cancer RAPID Test to Aid in Diagnosis of Oral Cancer

Vigilant Biosciences Receives CE Mark for OncAlert® Oral Cancer RAPID Test to Aid in Diagnosis of Oral Cancer May 4, 2016 FORT LAUDERDALE, Florida Vigilant Biosciences, Inc. (“Vigilant”), a leading innovator and developer of solutions that aid in the early detection and intervention of cancer, today announced that it has CE Marked its OncAlert® Oral Cancer

© 2020 Vigilant Biosciences

Follow Us

3900001 Rev2